AGBL2 and synovitis: In support of this, serial US assessments in a cohort of anti-CCP2+ at-risk individuals suggest that subclinical synovitis occurs directly before the development of clinical synovitis [27] and the fact that the majority of anti-CCP2+ individuals with US synovitis who develop inflammatory arthritis do so within 12 months of follow-up [15, 16].